X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (9) 9
humans (7) 7
animals (6) 6
female (6) 6
middle aged (6) 6
cardiac & cardiovascular systems (5) 5
myocardial infarction - pathology (5) 5
dogs (4) 4
index medicus (4) 4
activation (3) 3
aged (3) 3
cardiotonic agents - administration & dosage (3) 3
cardiovascular (3) 3
coronary circulation - drug effects (3) 3
ischemia (3) 3
myocardial infarction (3) 3
peripheral vascular disease (3) 3
rats (3) 3
risk factors (3) 3
adenosine (2) 2
adult (2) 2
atrial fibrillation - blood (2) 2
atrial fibrillation - complications (2) 2
atrial fibrillation - epidemiology (2) 2
beta-thromboglobulin - analysis (2) 2
blood platelets - chemistry (2) 2
blood pressure - drug effects (2) 2
blood proteins - analysis (2) 2
cardiology (2) 2
cardiology and cardiovascular medicine (2) 2
cerebrovascular disorders - epidemiology (2) 2
cerebrovascular disorders - prevention & control (2) 2
comorbidity (2) 2
cyclic gmp - blood (2) 2
diabetes mellitus - epidemiology (2) 2
disease models, animal (2) 2
dose-response relationship, drug (2) 2
drugs (2) 2
echocardiography (2) 2
fibrinogen - analysis (2) 2
flow (2) 2
heart (2) 2
heart attacks (2) 2
heart failure (2) 2
hematology (2) 2
hemodynamics (2) 2
hemodynamics - drug effects (2) 2
hyperlipidemias - epidemiology (2) 2
hypertension - epidemiology (2) 2
infarction (2) 2
infusions, intravenous (2) 2
inhibition (2) 2
internal medicine (2) 2
multicenter (2) 2
myocardial infarction - drug therapy (2) 2
myocardial infarction - enzymology (2) 2
myocardial infarction - prevention & control (2) 2
myocardial ischemia - epidemiology (2) 2
myocardium - enzymology (2) 2
nitrates - blood (2) 2
nitric oxide - blood (2) 2
nitric oxide - physiology (2) 2
nitrites - blood (2) 2
phosphorylation (2) 2
protein kinase c - metabolism (2) 2
protein-serine-threonine kinases - metabolism (2) 2
reperfusion injury (2) 2
smoking - epidemiology (2) 2
thrombophilia - blood (2) 2
thrombophilia - epidemiology (2) 2
thrombophilia - etiology (2) 2
vasodilator agents - administration & dosage (2) 2
3-kinase (1) 1
5'-nucleotidase - blood (1) 1
5'-nucleotidase - metabolism (1) 1
abridged index medicus (1) 1
actin cytoskeleton (1) 1
acute coronary syndromes (1) 1
adenosine - administration & dosage (1) 1
adenosine - blood (1) 1
adenosine - metabolism (1) 1
adenosine - pharmacokinetics (1) 1
adenosine - pharmacology (1) 1
adenylyl-cyclase (1) 1
adjunct (1) 1
aged, 80 and over (1) 1
aldehyde dehydrogenase 1 (1) 1
aldh1 (1) 1
aldosterone (1) 1
aldosterone - administration & dosage (1) 1
aldosterone - pharmacology (1) 1
alpha (1) 1
angioplasty (1) 1
angiotensin ii type 1 receptor blockers - therapeutic use (1) 1
angiotensin receptor antagonists - administration & dosage (1) 1
angiotensin receptor blocker (1) 1
angiotensin-converting enzyme inhibitors - therapeutic use (1) 1
apoptosis (1) 1
apoptosis - drug effects (1) 1
arrhythmia (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2009, Volume 53, Issue 8, pp. 709 - 717
Objectives The purpose of this study was to investigate whether liposomal adenosine has stronger cardioprotective effects and fewer side effects than free... 
Cardiovascular | Internal Medicine | adenosine | drug delivery system | liposome | myocardial infarction | INFARCTION | MULTICENTER | CARDIAC & CARDIOVASCULAR SYSTEMS | STERICALLY STABILIZED LIPOSOMES | THERAPY | PROTECTION | IN-VIVO | REPERFUSION INJURY | ADJUNCT | RECEPTOR ACTIVATION | BRIEF ISCHEMIA | Adenosine - pharmacokinetics | Rats, Wistar | Vasodilator Agents - pharmacokinetics | Fluorescence | Male | Drug Carriers | Dose-Response Relationship, Drug | Myocardial Reperfusion Injury - pathology | Myocardial Infarction - pathology | Myocardium - metabolism | Blood Pressure - drug effects | Vasodilator Agents - pharmacology | Polyethylene Glycols | Cardiotonic Agents - pharmacokinetics | Rats | Adenosine - pharmacology | Cardiotonic Agents - pharmacology | Myocardial Infarction - metabolism | Adenosine - administration & dosage | Myocardial Reperfusion Injury - metabolism | Animals | Cardiotonic Agents - administration & dosage | Liposomes - metabolism | Infusions, Intravenous | Vasodilator Agents - administration & dosage | Liposomes - pharmacokinetics | Myocardial Reperfusion Injury - prevention & control | Drugs | Sects | Adenosine | Drug delivery systems | Electron microscopy | Polyols | Theophylline | Vehicles | Medical colleges | Research institutes | Heart | Heart rate | Heart attacks | Ischemia | Hydration | Rodents | Lipids | Permeability | Experiments | Drug dosages
Journal Article
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 370, Issue 9597, pp. 1483 - 1493
Journal Article
Modern Pathology, ISSN 0893-3952, 01/2013, Volume 26, Issue 1, pp. 117 - 124
Journal Article
Cardiovascular Drugs and Therapy, ISSN 0920-3206, 1/2005, Volume 19, Issue 1, pp. 33 - 40
Although recent studies suggest that erythropoietin (EPO) may reduce multiple features of the myocardial ischemia/reperfusion injury, the cellular mechanisms... 
ventricular arrhythmia | ischemia-reperfusion injury | Medicine & Public Health | phosphatidylinositol-{3} {kin}ase | myocardial infarction | apoptosis | Cardiology | erythropoietin | Myocardial infarction | Ventricular arrhythmia | Ischemia-reperfusion injury | Phosphatidylinositol-3 kinase | Erythropoietin | Apoptosis | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | 3-KINASE | RALOXIFENE | phosphatidylinositol-3 kinase | RECOMBINANT-HUMAN-ERYTHROPOIETIN | VENTRICULAR-FIBRILLATION | INJURY | ISCHEMIC-HEART | INHIBITION | PHARMACOLOGY & PHARMACY | C-ZETA | Phosphorylation | Apoptosis - drug effects | Erythropoietin - therapeutic use | Humans | Phosphatidylinositol 3-Kinases - metabolism | Recombinant Proteins | Cardiotonic Agents - therapeutic use | Dose-Response Relationship, Drug | Ventricular Fibrillation - pathology | Myocardial Infarction - pathology | Ventricular Fibrillation - physiopathology | Myocardial Infarction - physiopathology | Protein-Serine-Threonine Kinases - metabolism | Disease Models, Animal | Myocardial Infarction - enzymology | In Situ Nick-End Labeling | Proto-Oncogene Proteins - metabolism | Ventricular Fibrillation - prevention & control | Erythropoietin - administration & dosage | Ventricular Fibrillation - enzymology | Blood Cell Count | Proto-Oncogene Proteins c-akt | Myocardial Reperfusion - adverse effects | Animals | Cardiotonic Agents - administration & dosage | Dogs | Myocardial Infarction - prevention & control | Coronary Circulation - drug effects | Arrhythmia
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 11/1997, Volume 17, Issue 11, pp. 3191 - 3195
Journal Article
Circulation Research, ISSN 0009-7330, 08/2000, Volume 87, Issue 4, p. 303
  Protein kinase C (PKC) plays an important role in ischemic preconditioning (IP). Because (1) tyrosine kinase is located at the downstream of PKC for IP in... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.